On National Duty- Foray into sectors where the nation needs to establish a foothold

On National Duty

Contract manufacturing has emerged as a significant trend in the manufacturing
sector, transforming the way businesses operate. This process involves one
company outsourcing its manufacturing tasks to another specialized company,
often referred to as a contract manufacturer or third-party manufacturer. This
allows the contracting company to focus on its core competencies while leveraging
the expertise and resources of the contract manufacturer.
In essence, contract manufacturing entails the production of goods by one
company under the brand name of another. The contracted manufacturer creates
products according to the specifications and designs provided by the outsourcing
company. This arrangement enables the contracting company to market and sell
the products under its own brand name without having to invest extensively in
manufacturing facilities and capabilities. Companies can opt to outsource either
the entire manufacturing process or specific stages to one or more third-party
manufacturers based on their requirements. This flexibility makes contract
manufacturing suitable for both large original equipment manufacturers (OEMs)
with substantial customer orders and smaller enterprises lacking comprehensive
manufacturing infrastructure. In recent years, the contract manufacturing
industry has experienced significant growth. For instance, in India, the Contract
Manufacturing Organization (CMO) Market is anticipated to expand from USD
19.63 billion in 2023 to approximately USD 38.92 billion by 2028. This projected
growth is driven by a variety of factors, including the increasing demand for
injectable drugs, particularly in cancer research.
Mr. Zulfequar Rizvi also known as Mr. Zeke Rizvi is a renowned marketer well
known in his field for his professional skills and work ethics. He has worked with
a variety of clients and is enthusiastic on meeting new people/projects. Mr. Rizvi
brings his expertise in governance, advocacy, and networks to the company. He
is responsible for advising leadership on its possible partnerships, compliance
approvals, collaborations, and potential funding sources in India as well as
globally. His role includes a comprehensive consult to help identify gaps and
opportunities, a comprehensive report that includes a project plan with timelines
and milestones, a cost analysis & schedule for execution. He was featured under
Brand Promotion/ Connect Story in Forbes India magazine- “Independence Day
Edition” which speaks volumes to work done by himself. To add his accolades, He
was also awarded for the ‘Influential Marketer of the Year Award’ under Iconic
Achievers’ Awards from WBR Corp. He was recently awarded at International
Iconic Award 2023 for his services and excellence in Healthcare.
Mr. Rizvi is all set to collaborate with an international manufacturer to facilitate
Contract manufacturing in a specialized and niche category. While the exact
details and specifics of this collaboration are currently under wraps, they will be
disclosed subsequent to obtaining the necessary approvals and ensuring.
compliance with regulations. This type of contract sets out the requirements,
which the manufacturer must meet concerning the quality of the products,
certification, quantities, conditions and dates of delivery, etc. It also establishes
guidelines for the inspection and testing of the products set forth by the company
which contracts out the manufacture, or by its own clients. Furthermore, it also
outlines modifications to orders, as well as guarantees and compensation in case
of breach of contract. The market is also influenced by the rising technological
advancements and cost effectiveness.
In conclusion, contract manufacturing has become a pivotal strategy for
companies seeking to optimize their operations and market reach. Its ability to
enhance efficiency, reduce costs, and tap into specialized expertise makes it a
compelling choice for businesses across various sectors. In October 2021,
Boehringer Ingelheim International, had inaugurated its state-of-the-art
biopharmaceutical production facility Large Scale Cell Culture (LSCC) in Vienna,
Austria, with an investment volume of more than 700 million EUR, which is the
single largest investment in the company’s history. As demonstrated by Mr. Rizvi’s
impending collaboration, this trend is set to continue evolving and shaping the
manufacturing landscape. The rising demand for contract manufacturing with
improved accuracy and less time constraint pushes the key players for strategic
initiatives. Owning contract manufacturing frees up the overhead charges
required to invest in machinery, material, and another workforce, simplifying the
production process and streamlining the supply chain by reducing the overall cost.
He continues to foray into sectors where the country needs to establish a foothold.
He will look at these opportunities as part of his national duty


Please enter your comment!
Please enter your name here